Core Insights - Medline, a medical supplies giant, made its debut on the Nasdaq on December 17, marking the largest IPO of the year with a stock price of $29, which surged over 40% on its first day, leading to a market capitalization of $66 billion [1] - The IPO raised $6.265 billion, securing the top position for global IPOs in 2025 and setting a record for the largest IPO in the U.S. since 2021, providing a significant boost to the year-end capital markets [1] - Medline's successful listing has positively impacted market confidence for 2026, with several companies under Blackstone and EQT planning to go public, and potential large IPOs like SpaceX expected to follow suit [1] Industry Summary - Despite ongoing external challenges, over 200 companies have completed IPOs in the U.S. this year, raising a total of over $46 billion [1] - Medline's performance is seen as a strong conclusion for the U.S. IPO market in 2025, potentially influencing future market activities and investor sentiment [1]
快讯 | 募资62.65亿美金！今年最大美股IPO来了！